John Davitt, MD

Articles by John Davitt, MD

Improving Shared Decision-Making in Endometriosis Care

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

September 9th 2026

In "Improving Shared Decision-Making in Endometriosis Care," the panel opens Section 3 by asking why medical management still lags in everyday practice.

Monitoring Safety and Symptom Relief During Endometriosis Therapy

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

September 2nd 2026

In "Monitoring Safety and Symptom Relief During Endometriosis Therapy," Dr. Davitt details the practical monitoring plan he follows once a patient begins therapy.

Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

September 2nd 2026

This episode, "Add-Back Therapy: Balancing Efficacy and Safety in Endometriosis," features Dr. Davitt reviewing 12-month efficacy and safety data on add-back therapy.

Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 26th 2026

In "Long-Term Data on Relugolix Combination Therapy for Endometriosis Pain," the panel reviews two-year outcomes from a major open-label extension trial.

Choosing Between Newer GnRH Antagonist Therapies for Endometriosis

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 26th 2026

In "Choosing Between Newer GnRH Antagonist Therapies for Endometriosis," Dr. Davitt compares two newer, FDA-approved options for treating endometriosis-associated pain.

Comparing GnRH Agonists and Antagonists for Endometriosis Pain

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 19th 2026

In "Comparing GnRH Agonists and Antagonists for Endometriosis Pain," Dr. Davitt explains the mechanistic split between two major drug classes used to manage endometriosis pain.

Why Estrogen Suppression Anchors Endometriosis Treatment

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 19th 2026

In "Why Estrogen Suppression Anchors Endometriosis Treatment," the panel explores the biological rationale that makes estrogen suppression the backbone of medical therapy.

Weighing Surgical Versus Medical Management in Endometriosis

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 12th 2026

"Weighing Surgical Versus Medical Management in Endometriosis" takes up the question of when a patient's endometriosis care should shift from medicine to the operating room.

Understanding the Different Types of Endometriosis Lesions

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 12th 2026

In "Understanding the Different Types of Endometriosis Lesions," our experts turn to the primary goals of treatment and the disease's four distinct subtypes.

ACOG's New Guidance on Diagnosing Endometriosis Without Surgery

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 5th 2026

In "ACOG's New Guidance on Diagnosing Endometriosis Without Surgery," Dr. Davitt reflects on what ACOG's March 2026 guideline update means in daily practice.

Why Endometriosis Diagnosis Is Often Delayed by a Decade

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

August 5th 2026

In "Why Endometriosis Diagnosis Is Often Delayed by a Decade," the panel unpacks the factors behind a diagnostic delay that can stretch a decade.

Endometriosis Risk Factors and the Cost of Chronic Pelvic Pain

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

July 29th 2026

Identifying who is most at risk for endometriosis, and recognizing its hallmark symptoms early, can shorten the path to diagnosis and reduce its enormous economic toll.

Endometriosis Prevalence: Why the True Burden Is Underrecognized

ByAndrea Lukes, MD, MHSc, FACOG,Rosanne Kho, MD,John Davitt, MD

July 29th 2026

Endometriosis affects far more women than commonly cited figures suggest, and the gap between perception and reality shapes how the disease is diagnosed and treated.